However, it remains uncertain whether the alternative—unstructured clinical approaches without the use of risk-assessment tools—lead to improved prediction and outcomes. It has been argued that such tools also
TRIAL REGISTRATION: ClinicalTrials.gov, no. NCT01686802 . 2017 Canadian Medical Association or its licensors.doi:10.1503/cmaj.170017Poonai, NaveenDatoo, NatashaAli, SaminaCashin, MeganDrendel...
Authors' conclusions This systematic review has not found evidence to show that HBOT improves clinical outcomes when applied during the acute presentation of ischaemic stroke. While evidence from the...